Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited tumor-infiltrating lymphocytes (TILs) may be ...

Updated findings from a phase 2 study investigating the IL-2–binding monoclonal antibody AU-007 show a manageable safety ...

Mixing turmeric and honey may have health benefits such as helping weight loss and decreasing inflammation. Dietitians reveal ...

Fresenius Kabi, an operating company of Fresenius, announced today that the Centers for Medicare and Medicaid Services (CMS) issued a permanent, product-specific billing code for Otulfi® ...

Researchers from the Ernst Strüngmann Institute for Neuroscience, the MIND Foundation, alongside other collaborators, have ...

PASADENA, CA, USA I April 26, 2025 I GenVivo, Inc., a clinical-stage biopharmaceutical company pioneering a patented, off-the-shelf vector platform that ...

Zai Lab (ZLAB) will present new data from studies evaluating two of its internally developed, next-generation, investigational oncology ...

Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch and ...

Amtagvi® and its accompanying design marks, Proleukin ®, Iovance ®, and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other ...

A new study presented at ESCMID Global 2025 highlights interleukin-6 (IL-6) as a fast, accurate biomarker for early sepsis detection in neonates, children, and pregnant women.